A Republican bill with 6 Republican cosponsors · See all 6 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "ISLET Act," aims to regulate human cadaveric islets for transplantation as organs. It specifically amends the Public Health Service Act to include human cadaveric islets alongside the pancreas. The Act clarifies that these islets are not considered drugs, biological products, or human cells, tissues, or cellular or tissue-based products. Additionally, it requires the Secretary of Health and Human Services to update specific regulations within one year. Finally, the Secretary must report to Congress on the progress of these regulatory updates within six months.
Yes· 3 of 4
- Scored +5
Does this make health care easier to get in general?
The bill establishes a regulatory framework for human cadaveric islet transplantation by classifying them as organs.
- Scored +3
Does this put more money into medical research?
By clarifying the regulatory status of islets, the bill facilitates the clinical implementation of endocrine transplantation.
- Scored +3
Would people with disabilities be better off under this?
The bill supports advanced medical treatments that can manage chronic endocrine conditions.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Regulatory Classification: By amending the Public Health Service Act to include human cadaveric islets, the bill establishes a framework to regulate these islets as organs (Section 2(a)).
-
Clearer Definitions: The bill provides clarification that human cadaveric islets are not defined as drugs, biological products, or certain human cell-based products, which clarifies their legal status (Section 2(b)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — The bill establishes a regulatory framework for human cadaveric islet transplantation by classifying them as organs. Does this put more money into medical research? — By clarifying the regulatory status of islets, the bill facilitates the clinical implementation of endocrine transplantation.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — The bill supports advanced medical treatments that can manage chronic endocrine conditions.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires the Secretary of Health and Human Services to report progress on regulatory updates to Congress.
- 9/1/2026
- 1 Cosponsor added.
- 6/11/2026
- 1 Cosponsor added.
- 5/11/2026
- 1 Cosponsor added.
- 4/21/2026
- 1 Cosponsor added.
- 3/24/2026
- 1 Cosponsor added.
- 3/19/2026
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Don BaconRepublican · Nebraska
Robert BresnahanRepublican · Pennsylvania
Andrew GarbarinoRepublican · New York
Brandon GillRepublican · Texas
Nick LaLotaRepublican · New York
Tracey MannRepublican · Kansas